LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 7 of total 7

Search options

  1. Article ; Online: PlexinD1 Is a Novel Transcriptional Target and Effector of Notch Signaling in Cancer Cells.

    Rehman, Michael / Gurrapu, Sreeharsha / Cagnoni, Gabriella / Capparuccia, Lorena / Tamagnone, Luca

    PloS one

    2016  Volume 11, Issue 10, Page(s) e0164660

    Abstract: The secreted semaphorin Sema3E controls cell migration and invasiveness in cancer cells. Sema3E-receptor, PlexinD1, is frequently upregulated in melanoma, breast, colon, ovarian and prostate cancers; however, the mechanisms underlying PlexinD1 ... ...

    Abstract The secreted semaphorin Sema3E controls cell migration and invasiveness in cancer cells. Sema3E-receptor, PlexinD1, is frequently upregulated in melanoma, breast, colon, ovarian and prostate cancers; however, the mechanisms underlying PlexinD1 upregulation and the downstream events elicited in tumor cells are still unclear. Here we show that the canonical RBPjk-dependent Notch signaling cascade controls PlexinD1 expression in primary endothelial and cancer cells. Transcriptional activation was studied by quantitative PCR and promoter activity reporter assays. We found that Notch ligands and constitutively activated intracellular forms of Notch receptors upregulated PlexinD1 expression; conversely RNAi-based knock-down, or pharmacological inhibition of Notch signaling by gamma-secretase inhibitors, downregulated PlexinD1 levels. Notably, both Notch1 and Notch3 expression positively correlates with PlexinD1 levels in prostate cancer, as well as in other tumor types. In prostate cancer cells, Sema3E-PlexinD1 axis was previously reported to regulate migration; however, implicated mechanisms were not elucidated. Here we show that in these cells PlexinD1 activity induces the expression of the transcription factor Slug, downregulates E-cadherin levels and enhances cell migration. Moreover, our mechanistic data identify PlexinD1 as a pivotal mediator of this signaling axis downstream of Notch in prostate cancer cells. In fact, on one hand, PlexinD1 is required to mediate cell migration and E-cadherin regulation elicited by Notch. On the other hand, PlexinD1 upregulation is sufficient to induce prostate cancer cell migration and metastatic potential in mice, leading to functional rescue in the absence of Notch. In sum, our work identifies PlexinD1 as a novel transcriptional target induced by Notch signaling, and reveals its role promoting prostate cancer cell migration and downregulating E-cadherin levels in Slug-dependent manner. Collectively, these findings suggest that Notch-PlexinD1 signaling axis may be targeted to impair prostate cancer cell invasiveness and metastasis.
    MeSH term(s) Animals ; Benzazepines/pharmacology ; Cadherins/genetics ; Cadherins/metabolism ; Cell Adhesion Molecules, Neuronal/antagonists & inhibitors ; Cell Adhesion Molecules, Neuronal/genetics ; Cell Adhesion Molecules, Neuronal/metabolism ; Cell Line, Tumor ; Cell Movement/drug effects ; Diamines/pharmacology ; Down-Regulation/drug effects ; Enzyme Inhibitors/pharmacology ; HEK293 Cells ; Human Umbilical Vein Endothelial Cells ; Humans ; Intracellular Signaling Peptides and Proteins ; Jagged-1 Protein/pharmacology ; Lung Neoplasms/metabolism ; Lung Neoplasms/pathology ; Membrane Glycoproteins ; Mice ; Mice, Inbred NOD ; Mice, SCID ; Microscopy, Fluorescence ; Promoter Regions, Genetic ; RNA Interference ; RNA, Messenger/metabolism ; RNA, Small Interfering/metabolism ; Receptors, Notch/antagonists & inhibitors ; Receptors, Notch/genetics ; Receptors, Notch/metabolism ; Signal Transduction/drug effects ; Snail Family Transcription Factors/genetics ; Snail Family Transcription Factors/metabolism ; Thiazoles/pharmacology ; Transplantation, Heterologous ; Up-Regulation/drug effects
    Chemical Substances 24-diamino-5-phenylthiazole ; Benzazepines ; Cadherins ; Cell Adhesion Molecules, Neuronal ; Diamines ; Enzyme Inhibitors ; Intracellular Signaling Peptides and Proteins ; JAG1 protein, human ; Jagged-1 Protein ; Membrane Glycoproteins ; PLXND1 protein, human ; RNA, Messenger ; RNA, Small Interfering ; Receptors, Notch ; SNAI1 protein, human ; Snail Family Transcription Factors ; Thiazoles ; 2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide (KK8645V7LE)
    Language English
    Publishing date 2016-10-17
    Publishing country United States
    Document type Journal Article
    ISSN 1932-6203
    ISSN (online) 1932-6203
    DOI 10.1371/journal.pone.0164660
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Downregulating Neuropilin-2 Triggers a Novel Mechanism Enabling EGFR-Dependent Resistance to Oncogene-Targeted Therapies.

    Rizzolio, Sabrina / Battistini, Chiara / Cagnoni, Gabriella / Apicella, Maria / Vella, Viviana / Giordano, Silvia / Tamagnone, Luca

    Cancer research

    2017  Volume 78, Issue 4, Page(s) 1058–1068

    Abstract: Neuropilins are a class of cell surface proteins implicated in cell migration and angiogenesis, with aberrant expression in human tumors. Here, we show that the expression of Neuropilin-2 (NRP2) controls EGFR protein levels, thereby impinging on ... ...

    Abstract Neuropilins are a class of cell surface proteins implicated in cell migration and angiogenesis, with aberrant expression in human tumors. Here, we show that the expression of Neuropilin-2 (NRP2) controls EGFR protein levels, thereby impinging on intracellular signaling, viability, and response to targeted therapies of oncogene-addicted cells. Notably, increased NRP2 expression in EGFR-addicted tumor cells led to downregulation of EGFR protein and tumor cell growth inhibition. NRP2 also blunted upregulation of an EGFR "rescue" pathway induced by targeted therapy in Met-addicted carcinoma cells. Cancer cells acquiring resistance to MET oncogene-targeted drugs invariably underwent NRP2 loss, a step required for EGFR upregulation. Mechanistic investigations revealed that NRP2 loss activated NFkB and upregulated the EGFR-associated protein KIAA1199/CEMIP, which is known to oppose the degradation of activated EGFR kinase. Notably, KIAA1199 silencing in oncogene-addicted tumor cells improved therapeutic responses and counteracted acquired drug resistance. Our findings define NRP2 as the pivotal switch of a novel broad-acting and actionable pathway controlling EGFR signaling, and driving resistance to therapies targeting oncogene-addiction.
    MeSH term(s) Cell Line, Tumor ; Cell Proliferation ; Down-Regulation ; Humans ; Neuropilin-2/genetics ; Neuropilin-2/metabolism ; Oncogenes ; Signal Transduction
    Chemical Substances Neuropilin-2 ; neuropilin-2, human
    Language English
    Publishing date 2017-12-11
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 1432-1
    ISSN 1538-7445 ; 0008-5472
    ISSN (online) 1538-7445
    ISSN 0008-5472
    DOI 10.1158/0008-5472.CAN-17-2020
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Neuropilin-1 upregulation elicits adaptive resistance to oncogene-targeted therapies.

    Rizzolio, Sabrina / Cagnoni, Gabriella / Battistini, Chiara / Bonelli, Stefano / Isella, Claudio / Van Ginderachter, Jo A / Bernards, René / Di Nicolantonio, Federica / Giordano, Silvia / Tamagnone, Luca

    The Journal of clinical investigation

    2018  Volume 128, Issue 9, Page(s) 3976–3990

    Abstract: Cancer cell dependence on activated oncogenes is therapeutically targeted, but acquired resistance is virtually unavoidable. Here we show that the treatment of addicted melanoma cells with BRAF inhibitors, and of breast cancer cells with HER2-targeted ... ...

    Abstract Cancer cell dependence on activated oncogenes is therapeutically targeted, but acquired resistance is virtually unavoidable. Here we show that the treatment of addicted melanoma cells with BRAF inhibitors, and of breast cancer cells with HER2-targeted drugs, led to an adaptive rise in neuropilin-1 (NRP1) expression, which is crucial for the onset of acquired resistance to therapy. Moreover, NRP1 levels dictated the efficacy of MET oncogene inhibitors in addicted stomach and lung carcinoma cells. Mechanistically, NRP1 induced a JNK-dependent signaling cascade leading to the upregulation of alternative effector kinases EGFR or IGF1R, which in turn sustained cancer cell growth and mediated acquired resistance to BRAF, HER2, or MET inhibitors. Notably, the combination with NRP1-interfering molecules improved the efficacy of oncogene-targeted drugs and prevented or even reversed the onset of resistance in cancer cells and tumor models. Our study provides the rationale for targeting the NRP1-dependent upregulation of tyrosine kinases, which are responsible for loss of responsiveness to oncogene-targeted therapies.
    MeSH term(s) Animals ; Cell Line, Tumor ; Drug Resistance, Neoplasm/genetics ; Female ; Gene Knockdown Techniques ; Humans ; MAP Kinase Signaling System ; Melanoma/drug therapy ; Melanoma/genetics ; Mice ; Mice, Inbred NOD ; Mice, SCID ; MicroRNAs/genetics ; Molecular Targeted Therapy ; Neoplasms/drug therapy ; Neoplasms/genetics ; Neuropilin-1/genetics ; Oncogenes ; Precision Medicine ; Proto-Oncogene Proteins B-raf/antagonists & inhibitors ; Proto-Oncogene Proteins B-raf/genetics ; Proto-Oncogene Proteins c-met/antagonists & inhibitors ; Proto-Oncogene Proteins c-met/genetics ; SOXE Transcription Factors/antagonists & inhibitors ; SOXE Transcription Factors/genetics ; Up-Regulation ; Xenograft Model Antitumor Assays
    Chemical Substances MIRN338 microRNA, human ; MicroRNAs ; NRP1 protein, human ; SOX10 protein, human ; SOXE Transcription Factors ; Neuropilin-1 (144713-63-3) ; MET protein, human (EC 2.7.10.1) ; Proto-Oncogene Proteins c-met (EC 2.7.10.1) ; BRAF protein, human (EC 2.7.11.1) ; Proto-Oncogene Proteins B-raf (EC 2.7.11.1)
    Language English
    Publishing date 2018-08-13
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 3067-3
    ISSN 1558-8238 ; 0021-9738
    ISSN (online) 1558-8238
    ISSN 0021-9738
    DOI 10.1172/JCI99257
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: A rationally designed NRP1-independent superagonist SEMA3A mutant is an effective anticancer agent.

    Gioelli, Noemi / Maione, Federica / Camillo, Chiara / Ghitti, Michela / Valdembri, Donatella / Morello, Noemi / Darche, Marie / Zentilin, Lorena / Cagnoni, Gabriella / Qiu, Yaqi / Giacca, Mauro / Giustetto, Maurizio / Paques, Michel / Cascone, Ilaria / Musco, Giovanna / Tamagnone, Luca / Giraudo, Enrico / Serini, Guido

    Science translational medicine

    2018  Volume 10, Issue 442

    Abstract: Vascular normalizing strategies, aimed at ameliorating blood vessel perfusion and lessening tissue hypoxia, are treatments that may improve the outcome of cancer patients. Secreted class 3 semaphorins (SEMA3), which are thought to directly bind ... ...

    Abstract Vascular normalizing strategies, aimed at ameliorating blood vessel perfusion and lessening tissue hypoxia, are treatments that may improve the outcome of cancer patients. Secreted class 3 semaphorins (SEMA3), which are thought to directly bind neuropilin (NRP) co-receptors that, in turn, associate with and elicit plexin (PLXN) receptor signaling, are effective normalizing agents of the cancer vasculature. Yet, SEMA3A was also reported to trigger adverse side effects via NRP1. We rationally designed and generated a safe, parenterally deliverable, and NRP1-independent SEMA3A point mutant isoform that, unlike its wild-type counterpart, binds PLXNA4 with nanomolar affinity and has much greater biochemical and biological activities in cultured endothelial cells. In vivo, when parenterally administered in mouse models of pancreatic cancer, the NRP1-independent SEMA3A point mutant successfully normalized the vasculature, inhibited tumor growth, curbed metastatic dissemination, and effectively improved the supply and anticancer activity of chemotherapy. Mutant SEMA3A also inhibited retinal neovascularization in a mouse model of age-related macular degeneration. In summary, mutant SEMA3A is a vascular normalizing agent that can be exploited to treat cancer and, potentially, other diseases characterized by pathological angiogenesis.
    MeSH term(s) Animals ; Antineoplastic Agents/pharmacology ; Antineoplastic Agents/therapeutic use ; Capillary Permeability/drug effects ; Cell Adhesion Molecules/metabolism ; Cell Movement/drug effects ; Cell Proliferation/drug effects ; Choroidal Neovascularization/drug therapy ; Choroidal Neovascularization/pathology ; Computer Simulation ; Drug Design ; Endothelial Cells/cytology ; Endothelial Cells/drug effects ; Mice, Transgenic ; Mutant Proteins/chemistry ; Mutant Proteins/metabolism ; Neoplasms/blood supply ; Neoplasms/pathology ; Nerve Tissue Proteins/metabolism ; Neuropilin-1/metabolism ; Protein Binding/drug effects ; Semaphorin-3A/agonists ; Semaphorin-3A/chemistry
    Chemical Substances Antineoplastic Agents ; Cell Adhesion Molecules ; Mutant Proteins ; Nerve Tissue Proteins ; Semaphorin-3A ; plexin ; Neuropilin-1 (144713-63-3)
    Language English
    Publishing date 2018-05-23
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 2518854-9
    ISSN 1946-6242 ; 1946-6234
    ISSN (online) 1946-6242
    ISSN 1946-6234
    DOI 10.1126/scitranslmed.aah4807
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Semaphorin7A regulates neuroglial plasticity in the adult hypothalamic median eminence.

    Parkash, Jyoti / Messina, Andrea / Langlet, Fanny / Cimino, Irene / Loyens, Anne / Mazur, Danièle / Gallet, Sarah / Balland, Eglantine / Malone, Samuel A / Pralong, François / Cagnoni, Gabriella / Schellino, Roberta / De Marchis, Silvia / Mazzone, Massimiliano / Pasterkamp, R Jeroen / Tamagnone, Luca / Prevot, Vincent / Giacobini, Paolo

    Nature communications

    2015  Volume 6, Page(s) 6385

    Abstract: Reproductive competence in mammals depends on the projection of gonadotropin-releasing hormone (GnRH) neurons to the hypothalamic median eminence (ME) and the timely release of GnRH into the hypothalamic-pituitary-gonadal axis. In adult rodents, GnRH ... ...

    Abstract Reproductive competence in mammals depends on the projection of gonadotropin-releasing hormone (GnRH) neurons to the hypothalamic median eminence (ME) and the timely release of GnRH into the hypothalamic-pituitary-gonadal axis. In adult rodents, GnRH neurons and the specialized glial cells named tanycytes periodically undergo cytoskeletal plasticity. However, the mechanisms that regulate this plasticity are still largely unknown. We demonstrate that Semaphorin7A, expressed by tanycytes, plays a dual role, inducing the retraction of GnRH terminals and promoting their ensheathment by tanycytic end feet via the receptors PlexinC1 and Itgb1, respectively. Moreover, Semaphorin7A expression is regulated during the oestrous cycle by the fluctuating levels of gonadal steroids. Genetic invalidation of Semaphorin7A receptors in mice induces neuronal and glial rearrangements in the ME and abolishes normal oestrous cyclicity and fertility. These results show a role for Semaphorin7A signalling in mediating periodic neuroglial remodelling in the adult ME during the ovarian cycle.
    MeSH term(s) Analysis of Variance ; Animals ; Antigens, CD/administration & dosage ; Antigens, CD/pharmacology ; Blotting, Western ; Enzyme-Linked Immunosorbent Assay ; Estradiol/analogs & derivatives ; Female ; Flow Cytometry ; Fluorescent Antibody Technique ; Image Processing, Computer-Assisted ; Immunohistochemistry ; Median Eminence/physiology ; Mice ; Neuroglia/metabolism ; Neuronal Plasticity/drug effects ; Neuronal Plasticity/physiology ; Ovariectomy ; Progesterone ; Rats ; Rats, Sprague-Dawley ; Real-Time Polymerase Chain Reaction ; Semaphorins/administration & dosage ; Semaphorins/pharmacology
    Chemical Substances Antigens, CD ; Sema7a protein, rat ; Semaphorins ; estradiol 3-benzoate (1S4CJB5ZGN) ; Progesterone (4G7DS2Q64Y) ; Estradiol (4TI98Z838E)
    Language English
    Publishing date 2015-02-27
    Publishing country England
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 2553671-0
    ISSN 2041-1723 ; 2041-1723
    ISSN (online) 2041-1723
    ISSN 2041-1723
    DOI 10.1038/ncomms7385
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Brain endothelial cells control fertility through ovarian-steroid-dependent release of semaphorin 3A.

    Giacobini, Paolo / Parkash, Jyoti / Campagne, Céline / Messina, Andrea / Casoni, Filippo / Vanacker, Charlotte / Langlet, Fanny / Hobo, Barbara / Cagnoni, Gabriella / Gallet, Sarah / Hanchate, Naresh Kumar / Mazur, Danièle / Taniguchi, Masahiko / Mazzone, Massimiliano / Verhaagen, Joost / Ciofi, Philippe / Bouret, Sébastien G / Tamagnone, Luca / Prevot, Vincent

    PLoS biology

    2014  Volume 12, Issue 3, Page(s) e1001808

    Abstract: Neuropilin-1 (Nrp1) guides the development of the nervous and vascular systems, but its role in the mature brain remains to be explored. Here we report that the expression of the 65 kDa isoform of Sema3A, the ligand of Nrp1, by adult vascular endothelial ...

    Abstract Neuropilin-1 (Nrp1) guides the development of the nervous and vascular systems, but its role in the mature brain remains to be explored. Here we report that the expression of the 65 kDa isoform of Sema3A, the ligand of Nrp1, by adult vascular endothelial cells, is regulated during the ovarian cycle and promotes axonal sprouting in hypothalamic neurons secreting gonadotropin-releasing hormone (GnRH), the neuropeptide controlling reproduction. Both the inhibition of Sema3A/Nrp1 signaling and the conditional deletion of Nrp1 in GnRH neurons counteract Sema3A-induced axonal sprouting. Furthermore, the localized intracerebral infusion of Nrp1- or Sema3A-neutralizing antibodies in vivo disrupts the ovarian cycle. Finally, the selective neutralization of endothelial-cell Sema3A signaling in adult Sema3aloxP/loxP mice by the intravenous injection of the recombinant TAT-Cre protein alters the amplitude of the preovulatory luteinizing hormone surge, likely by perturbing GnRH release into the hypothalamo-hypophyseal portal system. Our results identify a previously unknown function for 65 kDa Sema3A-Nrp1 signaling in the induction of axonal growth, and raise the possibility that endothelial cells actively participate in synaptic plasticity in specific functional domains of the adult central nervous system, thus controlling key physiological functions such as reproduction.
    MeSH term(s) Animals ; Axons/metabolism ; Axons/ultrastructure ; Brain/metabolism ; Endothelial Cells/metabolism ; Estrous Cycle/metabolism ; Fertility/physiology ; Gonadotropin-Releasing Hormone/metabolism ; Gonadotropin-Releasing Hormone/physiology ; Ligands ; Luteinizing Hormone/metabolism ; Mice ; Mice, Inbred C57BL ; Neuropilin-1/metabolism ; Neuropilin-1/physiology ; Rats ; Rats, Sprague-Dawley ; Semaphorin-3A/genetics ; Semaphorin-3A/metabolism ; Semaphorin-3A/physiology ; Signal Transduction
    Chemical Substances Ligands ; Semaphorin-3A ; Neuropilin-1 (144713-63-3) ; Gonadotropin-Releasing Hormone (33515-09-2) ; Luteinizing Hormone (9002-67-9)
    Language English
    Publishing date 2014-03-11
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 2126776-5
    ISSN 1545-7885 ; 1544-9173
    ISSN (online) 1545-7885
    ISSN 1544-9173
    DOI 10.1371/journal.pbio.1001808
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Dysregulation of Semaphorin7A/β1-integrin signaling leads to defective GnRH-1 cell migration, abnormal gonadal development and altered fertility.

    Messina, Andrea / Ferraris, Nicoletta / Wray, Susan / Cagnoni, Gabriella / Donohue, Duncan E / Casoni, Filippo / Kramer, Phillip R / Derijck, Alwin A / Adolfs, Youri / Fasolo, Aldo / Pasterkamp, Ronald J / Giacobini, Paolo

    Human molecular genetics

    2011  Volume 20, Issue 24, Page(s) 4759–4774

    Abstract: Reproduction in mammals is dependent on the function of specific neurons that secrete gonadotropin-releasing hormone-1 (GnRH-1). These neurons originate prenatally in the nasal placode and migrate into the forebrain along the olfactory-vomeronasal nerves. ...

    Abstract Reproduction in mammals is dependent on the function of specific neurons that secrete gonadotropin-releasing hormone-1 (GnRH-1). These neurons originate prenatally in the nasal placode and migrate into the forebrain along the olfactory-vomeronasal nerves. Alterations in this migratory process lead to defective GnRH-1 secretion, resulting in heterogeneous genetic disorders such as idiopathic hypogonadotropic hypogonadism (IHH), and other reproductive diseases characterized by the reduction or failure of sexual competence. Combining mouse genetics with in vitro models, we demonstrate that Semaphorin 7A (Sema7A) is essential for the development of the GnRH-1 neuronal system. Loss of Sema7A signaling alters the migration of GnRH-1 neurons, resulting in significantly reduced numbers of these neurons in the adult brain as well as in reduced gonadal size and subfertility. We also show that GnRH-1 cells differentially express the Sema7 receptors β1-integrin and Plexin C1 as a function of their migratory stage, whereas the ligand is robustly expressed along developing olfactory/vomeronasal fibers. Disruption of Sema7A function in vitro inhibits β1-integrin-mediated migration. Analysis of Plexin C1(-/-) mice did not reveal any difference in the migratory process of GnRH-1 neurons, indicating that Sema7A mainly signals through β1-integrin to regulate GnRH-1 cell motility. In conclusion, we have identified Sema7A as a gene implicated in the normal development of the GnRH-1 system in mice and as a genetic marker for the elucidation of some forms of GnRH-1 deficiency in humans.
    MeSH term(s) Animals ; Antigens, CD/metabolism ; Axons/metabolism ; Brain/embryology ; Brain/pathology ; Cell Count ; Cell Movement ; Fertility ; Gonadotropin-Releasing Hormone/metabolism ; Gonads/abnormalities ; Gonads/embryology ; Gonads/metabolism ; Gonads/pathology ; Humans ; Integrin beta1/metabolism ; Male ; Mice ; Nerve Tissue Proteins/metabolism ; Neurons/metabolism ; Neurons/pathology ; Olfactory Bulb/embryology ; Olfactory Bulb/metabolism ; Protein Precursors/metabolism ; Receptors, Cell Surface/metabolism ; Semaphorins/deficiency ; Semaphorins/metabolism ; Signal Transduction ; Testis/embryology ; Testis/metabolism ; Testis/pathology ; Vomeronasal Organ/embryology ; Vomeronasal Organ/metabolism
    Chemical Substances Antigens, CD ; Integrin beta1 ; Nerve Tissue Proteins ; Plxna3 protein, mouse ; Protein Precursors ; Receptors, Cell Surface ; Sema7a protein, mouse ; Semaphorins ; progonadoliberin I ; Gonadotropin-Releasing Hormone (33515-09-2)
    Language English
    Publishing date 2011-09-08
    Publishing country England
    Document type Journal Article ; Research Support, N.I.H., Intramural ; Research Support, Non-U.S. Gov't
    ZDB-ID 1108742-0
    ISSN 1460-2083 ; 0964-6906
    ISSN (online) 1460-2083
    ISSN 0964-6906
    DOI 10.1093/hmg/ddr403
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top